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ABSTRACT
Cataracts are a result of age-related protein aggregate formation in the eye lens, and the leading
cause of blindness worldwide. α-crystallin, a small heat shock protein, acts a molecular chaperone
that serves as the primary defense mechanism against protein aggregate formation in the lens.
Recent evidence suggest amyloid formation in the lens may contribute to cataract formation, and
that β-amyloid is present in lens epithelia of age-related cataracts. Previous studies have shown that
αB-crystallin in other parts of the body, such as the brain, is protective against neurodegenerative
diseases such as Alzheimer’s disease that are associated with plaque deposits containing β-amyloid.
In vitro, αB-crystallin inhibits fibril elongation of β-amyloid. However, the capacity of native lens
crystallin protection against β-amyloid formation is still unclear. The aim of this thesis was to
determine if the native lens specific αL-crystallin, a 3:1 ratio of the isoforms αA- and αB-crystallin,
would prevent the fibril elongation of β-amyloid comparatively to αB-crystallin.
Thioflavin T (ThT) based chaperone assays, biochemical analysis by SDS-PAGE, and
structural characterization by electron microscopy were used to determine if αL-crystallin can
prevent fibril elongation of the amyloidogenic peptide Aβ 1-42. Detection of β-amyloid formation
by ThT assay showed that αL-crystallin prevented fibril nucleation/elongation, but was less
effectively than αB-crystallin. Assessment of co-aggregation of the chaperone/β-amyloid complex
by SDS-PAGE were inconclusive. However, negative stain electron micrographs showed that αLcrystallin interacted effectively with β-amyloid fibrils under varying stoichiometric ratios. From
these data, it was found that αL-crystallin was an effective chaperone for β-amyloid in vitro. Further
experimentation could help understand the mechanism behind αL-crystallin function against
preventing the formation of amyloid species in the eye lens.

INTRODUCTION
Crystallins in the lens and their role in cataract formation

Cataract is the leading cause of blindness worldwide, representing 51% of the world blindness or about 20
million people. In developed countries, cataracts may be treated with a simple surgery; however, in many
countries there are barriers that prevent access to this surgery such as cost and resources, leading to eventual
loss of vision and blindness (Lampi et. al. 2014, Raj et. al. 2007). Therefore, there is a need to better
understand the molecular basis of this disease, so that we may develop more effective forms of treatment
that can be widely distributed to a variety of populations.
At the molecular level, cataract formation is the result of age-related protein aggregation within the eye lens
(Truscott and Friedrich 2019, Moreau et. al. 2012). The eye lens is saturated with a class of proteins, known
as crystallins, that exist in a unique cellular environment. Unlike most proteins in our body, proteins within
lens fiber cells are never turned over, meaning that they exist in the avascular lens for our entire lifetime,

all while being subjected to a decade of environmental stress, such as chemical and UV-damage and posttranslational modification. Ultimately, this damage results in loss of proteostasis and eventually leads to
protein degradation and amorphous and fibrillar aggregation of the lens crystallins that form light-scattering
opacities, known as cataracts.
There are three types of crystallins that exist in the lens, α-crystallin, β-crystallin and γ-crystallin which
make up 90% of the dry mass in the human eye lens (Horwitz et. al., 1999). The crystallin under study, αcrystallin, is a member of the small heat shock protein (sHsp) family and the major protein in the eye lens.
The sHsp’s act as a molecular chaperone that sequesters misfolded proteins, a function that serves to
maintain the transparency of the lens (Basha et. al. 2012, Carra et. al. 2017). The sHsps are ATPindependent, and are activated under the cellular stress response. They act as a “holdase” by complexing to
misfolded client proteins and holding them until they can be repaired or degraded. Through the cooperation
with other ATP-dependent chaperones, sHsp’s provide a pathway for proteins to properly fold from
unfolded state (U) to native folded state (N) as shown in Figure 1 (Ecroyd and Carter, 2008). Disruption in
chaperone function leads to the off-folding pathways. The β-crystallin and γ-crystallin subtypes perform
primarily structural functions and contribute to the refractive index of the lens.
There are two different types (or isoforms) of α-crystallin, known as αA-crystallin and αB-crystallin. While
αA-crystallin is specific to the lens, αB-crystallin is constitutively expressed throughout the body, including
the brain, cardiac and skeletal muscle, and the lungs. αB-crystallin has been postulated to help prevent other
protein aggregation diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) in the brain
and cardiomyopathy in the heart (Hayashi et. al. 2021, Rajasekaran et. al. 2007). In the eye lens, these two
isoforms co-assemble into a large polydisperse oligomeric structures, which together form the primary
defense mechanism against age-related aggregate formations. While comprehensive mechanisms of how
cataracts are formed and how α-crystallin performs its chaperone mechanism remain to be elucidated, it is
largely believed that cataracts disease is primarily attributed to age-related dysfunction of the lens
chaperone leading to protein aggregation and disease pathologies (Haslbeck et. al. 2016, de Jong et. al.
1993).
In the human lens, αA- and αB-crystallin are expressed an approximate 3:1 ratio of αA:αB. However, this
ratio does vary with age (Ecroyd and Carver 2008). The two different isoforms each have a mass of about
20 kDa and form into hetero-oligomeric species of up to a Mega-Dalton in mass. Previous work has showed
low-resolution CryoEM models that provide an important foundation for understanding the full-length
structure of αB- and αA-crystallin, as well as NMR and X-ray crystallography of sub-domains that have
given important high-resolution details of the monomeric and dimeric structure of α-crystallin (Loquet et.
al. 2018, Gremer et. al. 2017).
The α-crystallins are composed of three distinct domains, the α-crystallin domain (ACD), the N-terminal
domain (NTD) and the C-terminal extension (CTE). The ACD has been found to be well conserved among
the sHsps, suggesting an important function and possibly where client binding occurs. The NTD is
suggested to be vital in quaternary arrangement of the α-crystallin subunits and possibly client recognition.
The CTE is a 10- to 12-residue intrinsically disordered region of the protein and is highly mobile and polar,
making structural characterization difficult (Ecroyd and Carver 2008, Raman et. al. 2005, Shammas et. al.
2011). Despite this level of knowledge, there are still missing pieces of the larger puzzle to understanding
how polydisperse oligomers are formed; furthermore, the detailed mechanisms of client recognition and
client sequestration are still unknown.
αB-crystallin and its prevention in β-amyloid elongation
In brains of deceased Alzheimer’s disease patients, small heat shock proteins, primarily αB-crystallin, have
been shown to co-localize with plaque deposits and are present in increased concentration levels (Stege et.

al. 1999, Renkawek et. al. 1994). The formation of these plaque deposits is primarily due to aggregation of
the β-amyloid and the tau protein tangles, but also contain small heat shock proteins (sHsps) such as Hsp27
and αB-crystallin (Falcon et. al. 2019), suggesting a co-aggregation of the chaperone/filament complexes
(Narayanan et. al. 2006, Laganowsky et. al. 2010). The structure of β-amyloid is characteristic of other
amyloid species, it contains aggregates of protein that form highly ordered fibrils of heterogeneous linearity
(Gremer et. al. 2017, Shammas et. al. 2011). β-amyloid exists in two states, the “short tailed” variant which
is a 40-residue peptide with Val-40 as the C-terminal residue or the “long-tailed” variant which is 42residues long with a C-terminal residue of Ala-42 (Gremer et. al. 2017, Xu et. al. 2017).
In vitro, αB-crystallin has been shown to interact with β-amyloid and prevent fibril elongation (Shammas
et. al. 2011, Dehle et. al. 2010, Oliveira et. al. 2016). In fact, the sHsp αB-crystallin has been shown to
inhibit formation of a variety of amyloids in vitro, including β-amyloid, superoxide dismutase 1, β2microglobulin, α-synuclein, tau, and apoC-II (Raman et. al. 2005, Yerbury et. al. 2013, Cox and Ecroyd
2017, Baughman et. al. 2018, Binger et. al. 2013, Selig et. al. 2020, Knowles et. al. 2014). The interaction
between β-amyloid and αB-crystallin has been shown to be useful as a model client for in vitro structurefunction studies (Goldstein et. al. 2004).
β-amyloid and its presence in the eye lens.
In recent literature, it has been found that β-amyloid is present in age related cataract lens epithelia. It has
been proposed that β-amyloid plays a vital role in the oxidative stress response pathway that occurs from
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Figure 1. The off-folding pathways of protein folding and unfolding, A protein in its native state (N) will
unfold by a variety of intermediates to the unfolded state (U). Certain factors can disrupt this process, such
as time, that can lead to the off-folding pathways by the disordered amorphous aggregation pathway in
which the aggregate becomes irreversibly precipitated, or by the amyloid fibril off-folding pathway that
eventually leads to highly ordered amyloid species. Adapted from Ecroyd and Carver 2009.

oxidative damage in the lens epithelia and leads to the formation of age-related cataracts (Xu et. al. 2017).
β-amyloid reaches the eye lens from its precursor protein, amyloid-β precursor protein (APP), through
sequential enzymatic cleavages by β- and γ-secretase (De Strooper et. al. 2000, Xu, et. al. 2017). However,
details concerning the mechanism by which β-amyloids in the eye lens contribute to cataract formation are
still not clear, due in part to a lack of structural and functional characterization between the lens α-crystallins
and β-amyloid fibrilization.
It has been postulated that β-amyloid is especially present in the eye lens epithelia in patients who are
clinically diagnosed with neurodegenerative diseases such as in AD and Down syndrome (DS) (Xu et. al.
2017, Moncaster et. al. 2010). While staining in post-mortem lenses reveals that those with
neurodegenerative diseases express higher levels of APP and β-amyloid in the lens, these are also present
in healthy eye lenses. Either cataract opacities are inevitable as the population ages, or β-amyloid also plays
a beneficial role in the lens and other tissues in small concentrations (Xu et. al. 2017, Lee et. al. 2004, Dehle
et. al. 2010).
The kinetic pathway by which β-amyloid fibrils are formed is of particular importance to understanding the
role that β-amyloid plays in the formation of cataracts and neurodegenerative disease. The first kinetic
process is the nucleation of the monomeric protein to form fibril seeds, where the mechanism is still
unspecified. The second kinetic process is the elongation of the fibril, by incorporating additional
monomers into the structure. The third process is the increase of growth sites at the end of the fibril by
fragmentation of the fibril structure. This final kinetic process causes exponential growth kinetics
(Shammas et. al. 2011, Knowles et. al. 2009, Tanaka et. al. 2006).
While the interaction between αB-crystallin and β-amyloid has been well-established, the interaction
between β-amyloid and the lens-specific αA-crystallin and/or the native αA/αB-crystallin (αL) have not yet
been characterized. Therefore, it is unclear of this lens chaperone can interact with and/or prevent β-amyloid
nucleation or elongation using a similar mechanism. This may also help to elucidate the reason that, despite
conditions in the human eye lens that should favor amyloid formation such as its acidic environment and
high protein content, its lack of metabolic activity or a maintenance system for regulating oxidative stress,
and its proteins that do not turnover and have a long half-life, amyloids are in low abundance in the lens.
This thesis aimed to further understand the structure and function of α-crystallin and the structural changes
that the chaperone undergoes to prevent aggregation of amyloidogenic clientele, and how age-related
changes in the structure of α-crystallin lead to cataract formation. Specifically, this focused on how the
native lens α-crystallin, αL-crystallin, interacted with β-amyloid in vitro to determine if αL-crystallin
suppressed β-amyloid fibril formation and elongation.
MATERIALS AND METHODS
Specimen preparation
The β-amyloid used for these experiments was human amyloid peptide β1-42 (Aβ 1-42) prepared
recombinantly and purchased from Alfa Aesar. A concentration of 400 µM Aβ 1-42 in 10 mM NaOH was
diluted down to 10 µM in assay buffer (20 mM HEPES pH 7.4, 1 mM EDTA, 100 mM NaCl) for fibrillation
assays.
Wildtype αB-crystallin was prepared with pET23a (+) plasmid transformed into E. coli BL21(DE3) cells.
The cells were grown by incubating at 37º C until optimal optical density (measured at 600 nm) of 0.6-1.0
was reached, and then expression was induced with 1 mM IPTG for 3 hours at 37º C. Cells were harvested
by centrifugation at 4k x g for 15 minutes and resuspended in 20 mM Tris-HCl (pH 8.0) with 4 mL per
gram cell pellet. For purification, the thawed cells were supplemented with DTT (1 mM, final

concentration) and PMSF (1 mM, final) and then lysed by sonication, after which additional PMSF was
added (1 mM, final). Lysed cells were ultracentrifuged at 40k x g for 30 minutes, and the supernatant was
treated with DNase I and put on ice for 45 minutes, and the lysate was then passed through a 0.22 µm filter.
For the chromatography step, DTT was added to lysate (1 mM, final), and the initial lysate was separated
by size-exclusion chromatography (SEC; S300 resin) equilibrated with 20 mM Tris-HCl (pH 8.0) and 1
mM EDTA. The fractions containing αB-crystallin were then applied to an anion exchange column
(monoQ), equilibrated with 20 mM Tris-HCl (pH 8.0), 2 mM EGTA, and 1 mM EDTA and eluted with a
NaCl gradient. The elution fractions with αB-crystallin were applied to an S6 SEC column equilibrated in
20 mM HEPES (pH 7.4), 100 mM NaCl, and 2 mM EDTA. The purity of protein was assessed by SDSPAGE, flash frozen, and stored at -80º C until needed. The protein concentration was calculated using the
molal extinction coefficient of 19,000 M-1 cm-1.
Native lens αL-crystallin was prepared in a similar manner to αB-crystallin except the cytoplasm was
obtained from ovine (sheep) eye lenses from Wolverine Meatpacking in lysis buffer containing 10mM TrisHCl (pH 8.0), 5mM EDTA and 5mM EGTA. The purification only differs from that of αB-crystallin in that
the cortex cytoplasm was applied to the S300 instead of the initial lysate, the pH of all buffers were at 7.4.
Also, the molar extinction coefficient used was 17,125 M-1 cm-1 and DTT (1 mM final concentration) was
added to final purified protein.
Thioflavin T based chaperone assay
A Tecan Infinite M200 Pro was used for the Thioflavin T fluorescence assays at 37º C. A single, top down
read with a multi-well format was used to obtain fluorescence measurements. The concentrations for αLcrystallin and αB-crystallin were prepared in 10 – 100x molar excess versus Aβ 1-42. A positive control
experiment (Aβ 1-42 only) and negative control experiment (αL-crystallin or αB-crystallin only and
lysozyme) were included. All reactions were run in triplicate. The final ThT concentration was 10 µM for
each condition. Sealing tape was used on the wells to prevent evaporation of the sample. The excitation
wavelength was 440 nm, and the emission wavelength was 485 nm. The plate used was a Thermo Fisher
Scientific-Nunclon 384 Flat Bottom Black Polystyrene plate. The excitation bandwidth was 9 nm, and the
emission bandwidth was 20 nm. The assay ran for 24 hours with a 4-minute interval time as shown in Figure
2. For the ThT assay, 10 µM β-amyloid was used in each well. The reaction was allowed to equilibrate at
37º C for 45 minutes before adding β-amyloid to induce the reaction.
SDS-PAGE analysis of soluble and insoluble aggregates
SDS-PAGE was performed using BioRad Precast Gradient gels to assess the solubility of chaperone-client
complexes. The samples used for SDS-PAGE were from the ThT fluorescence assay (full reaction sample)
and centrifuged at 4k x g for 10 minutes to produce a pelleted sample (insoluble) and a supernatant sample
(soluble). A 2x SDS-PAGE loading buffer was used in a 1:1 ratio (Thermo Fisher). The protein ladder used
to characterize the molecular weight of the samples was a Page Rule Standards Ladder from Thermo Fisher.
Into each lane, 2 µL of sample was added. The gels were run at 40 mA until completed. The gels were then
stained overnight with PageBlue with agitation. The gels were washed with Millipore Milli-Q water with
agitation and repeated until the gel was able to be quantified.
Structural characterization by negative stain electron microscopy
Electron microscopy grids were prepared on a 400-mesh copper sputter coated with 8 nm carbon and
specimens were negatively stained with 0.75% Uranyl Formate. Fibril samples were diluted to a final
concentration of 1.25 µM where the monomer contained Thioflavin T-free reaction buffer. The grids were

imaged on a Tecnai T12 with a pixel size of 4.37 A/pix and a target defocus on 1.61. Qualitative image
analysis was performed in Fiji. A bandpass filter of 60/3 pixels was used to process the micrographs.
Statistical analysis
Microsoft excel was used for windowed averaging of ThT fluorescence data. Since these experiments were
ran in triplicate, the standard error of the mean was calculated to account for systematic error.
AmyloFit was used to determine the half-times (T1/2) of β-amyloid formation for each experimental
condition and the Aβ 1-42 only control (Meisl et. al. 2016). Student t-test was used to determine the p-value
and the significance of T1/2 data.
RESULTS
Effects of native lens crystallins on β-amyloid formation
Thioflavin T (ThT) fluorescence assays are diagnostic of amyloidal structure (Meehan et. al. 2007, Xue et.
al. 2017). ThT is a model fluorophore detection reagent for amyloids because it forms highly selective
complexes with amyloid and amyloid-like fibril structures which cause an increase in fluorescence intensity
(Sulatskaya et. al. 2012, Biancalana et. al. 2010). Also, ThT does not show fluorescence enhancement in
the presence of amorphous protein aggregates or native state globules (Sulatskaya et. al. 2012, Alperstein
et. al. 2019).
ThT assays were ran at a constant temperature of 37º C in triplicate. Chaperone activities of αB-crystallin
and αL-crystallin were investigated using well established methods for an in vitro β-amyloid formation
assay (Raman et. al. 2005). Aβ 1-42 alone was used as a positive control, and lysozyme was used as a
negative control.
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Figure 2. Average change in Thioflavin T fluorescence for 10 µM Aβ 1-42 alone, or in 10 – 100x molar
excess of αL-crystallin (A) and αB-crystallin (B). A gain of 100 was used for the experiment and windowed
averaging of 10 values was used. A 4-minute cycle time was used with 360 kinetic cycles. Each condition
was run in triplicate and standard error of the mean was plotted for each condition.

Figure 2 show fluorescence data of αL-crystallin and αB-crystallin demonstrate a dose-dependent response
to varying molar ratios of Aβ 1-42 peptide. The delay in fluorescence intensity of αL-crystallin treated
samples, as compared to Aβ 1-42 alone (Figure 2A), is attributed to the decrease kinetics of amyloid
formation. However, at all ratios, the fluorescence intensity ultimately matched or exceeded the Aβ 1-42
after a time of ~14 hours, indicating that the αL-crystallin was not able to completely prevent elongation of
β-amyloid in these concentrations and reaches a saturation point. Similar results are obtained for αBcrystallin (Figure 2B). However, at a ratio of 10x, αB-crystallin showed complete suppression of fibril
formation. These data suggest that αL-crystallin inhibited β-amyloid elongation in presence of large excess
of Aβ 1-42 as shown by the delay of fluorescence. However, the reaction reached a point where the
chaperone was overwhelmed, and elongation continued to occur as shown by an increase in fluorescence
intensity at all ratios tested.
The inhibition of β-amyloid elongation was quantified by measuring the half-times of fibril growth kinetics
from each experimental condition using the program AmyloFit (Meisl et. al. 2016). Results are shown in
Table 1, where the half-time (T1/2) is reported in hours. The T1/2 values of αL-crystallin were longer (~150–
200%) for each condition and significantly longer at a ratio of 1:10 (P ≤ 0.5), as compared to Aβ 1-42 alone
(T1/2 = 5.972 +/- 1.850 hours) and showed a concentration dependent response. A similar trend is shown for
αB-crystallin treated samples; however, the T1/2 of 1:10 αB-crystallin could not be determined (N.D.) since
it did not show a peak in the fluorescence assay, indicating complete suppression of β-amyloid formation
under these conditions.
Table 1. The half-times (T1/2) for β-amyloid formation under varying experimental conditions for αLcrystallin and αB-crystallin. T1/2 values reported in hours obtained from AmyloFit software (Meisl et. al.
2016) (N.D. = not determined). (ns indicates P > 0.05, * indicates P ≤ 0.05)

Condition
Aβ 1-42 (control; 10 µM)
1:10 Aβ 1-42
αL-crystallin
1:20 Aβ 1-42
(0.1 – 1.0 µM)
1:50 Aβ 1-42
1:100 Aβ 1-42
1:10 Aβ 1-42
αB-crystallin
1:20 Aβ 1-42
(0.1 – 1.0 µM)
1:50 Aβ 1-42
1:100 Aβ 1-42

T1/2 (hours)
5.972 +/- 1.850
11.81 +/- 0.017*
10.68 +/- 0.476ns
9.033 +/- 0.540ns
8.749 +/- 1.499ns
N.D.
17.18 +/- 1.879*
10.99 +/- 0.084ns
8.503 +/- 1.914ns

Solubility analysis by SDS-PAGE
SDS-PAGE was used to monitor the interaction between α-crystallin and β-amyloid to determine if there
was co-aggregation between the two species. Aliquots were taken from the end of the ThT fluorescence
assay (full reaction; F) and centrifuged at 4k x g for 10 minutes to separate the supernatant (S) from the
insoluble pellet (P). The pellet was resuspended in S6 buffer (20 mM HEPES pH 7.4, 1 mM EDTA, 100
mM NaCl) (Figure 3). The first gel (Figure 3A) shows results obtained from experimental conditions of
αL-crystallin in the presence of 5, 10 and 20x excess Aβ 1-42 and αB-crystallin with 5x Aβ 1-42. In each
condition, the crystallins showed no presence in the pelleted sample and no difference between the control
conditions (Figure 3B). Detection of α-crystallin occurred only in the full reaction and the supernatant,
which indicated that it remained soluble following centrifugation.
The Aβ 1-42 control (Figure 3B) showed a streak from 180 – 130 kDa, which indicated that the aggregated
species was formed. Monomers of Aβ 1-42 are ~4.5 kDa, and there was no presence of the free Aβ 1-42

Figure 3. SDS-PAGE gels of a) experimental data obtained from the first ThT fluorescence assay and b)
standards used to compare the experimental concentrations to which were also fractions collected from the
ThT assay. From left to right each different condition contains a full reaction (F), pellet (P), and
supernatant (S). Each reaction containing amyloid was at a concentration of 125 µM β-amyloid.
peptide at this molecular weight. A seeded β-amyloid preparation was also assayed, and also appears as a
streak from 180 – 130 kDa, although this band was significantly fainter than the Aβ 1-42 alone, which
indicated that the seeded Aβ 1-42 formed its oligomeric assembly, although perhaps less efficiently.
Structural characterization of chaperone-amyloid complexes by electron microscopy
To validate that αL-crystallin was interacting with β-amyloid, negative stain electron microscopy (NSEM)
was used to monitor each condition following the fluorescence assays (Figure 4). Electron micrographs of
Aβ 1-42 control samples show evidence of long helical fibrillar structures (Figure 4E), a characteristic
feature of β-amyloid (Gremer et. al. 2017). These structures are in stark contrast in morphology to the
spherical oligomers displayed in the αL-crystallin control (Figure 4E, F), which provided a clear basis for
the examination of the experimental conditions. αL-crystallin control samples appear similar to previous
studies using NSEM with α-crystallin, which have shown that these chaperones are polydisperse oligomers
of ~16 nm diameter (Figure 4F) (Jehle et. al. 2011).
As shown in Figure 4A-C, β-amyloid fibrils grown in the presence of αL-crystallin appear similar to the
positive control in Figure 4D. However, in the 10x condition, an interaction of αL-crystallin with βamyloid can be clearly visualized, shown by the spherical structures located along the fibril (Figure 4A,
arrows). A higher ratio of αL-crystallin correlated with less fibrils in the micrograph and less elongation
of the fibril, as compared to controls. There was interaction between the chaperone and the fibril observed
in each condition, however, the number of bound αL-crystallin decreased as the ratio of β-amyloid to αLcrystallin increased (Figure 4B - C). Taken together, these data indicate that αL-crystallin forms a direct
association with elongated β-amyloid fibrils.
The 10:1 αB-crystallin condition showed even greater association with the fibril (Figure 4D). There were
less fibrils present in the micrograph and the fibrils that were present were saturated with αB-crystallin.
There was also a high concentration of free αB-crystallin which indicated that the chaperone had saturated
the amyloid fibril, consistent with the differences in effect observed by functional assays.
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Figure 4. Negative stain electron micrographs of experimental conditions and control conditions. αLcrystallin in varying concentrations and 10 µM β-amyloid were represented: 1:10 αL-crystallin in (A), 1:50
αL-crystallin in (B), 1:100 αL-crystallin in (C), and 1:10 αB-crystallin in (D). Control conditions were βamyloid in (E) and αL-crystallin in (F). Electron micrographs were captured by Russell McFarland in the
Reichow Laboratory, Department of Chemistry, Portland State University.

DISCUSSION
Cataracts is characterized by protein aggregation in the eye lens that cause light scattering opacities to form.
β-amyloid has recently been found to be also present in the eye lens and is present especially in postmortem
cataract lenses of patients who also had other neurodegenerative diseases (Xu et. al. 2017, Moncaster et. al.
2010). Suppression of amyloid formation has been shown previously with αB-crystallin (Dehle et. al. 2010);
however, this had not previously studied with the native lens crystallin, αL-crystallin. This thesis aimed to
determine whether αL-crystallin had a role in suppressing amyloid elongation in the eye lens.
The primary mode for determining whether αL-crystallin would prevent the elongation of β-amyloid was
by measuring the change in Thioflavin T fluorescence in varying ratios of α-crystallin to Aβ 1-42. ThT was
used for the detection of amyloid species due to its highly selective binding capabilities to amyloid species
and associated increase in fluorescence intensity (Sulatskaya et. al. 2012, Meehan et. al. 2007).
A limitation of the ThT fluorescence method used in this study is the slow kinetics of fibril formation,
which consume large quantities of time. In preliminary assays, seeded β-amyloid protocols were tested as
an approach to reduce the time of fibril formation. While both the seeded and non-seeded procedures
produced similar fibril growth curves, the use of β-amyloid seeds did not enhance the kinetics of fibril
formation under the conditions tested.
A decrease in fluorescence intensity in the presence of a-crystallin would indicate that fibril elongation was
being suppressed. Fluorescence assays contained varying concentrations form 10 – 100x molar excess Aβ142 versus αL-crystallin or αB-crystallin were used to measure the difference in amyloid suppression
between the two chaperone species (Figures 2A and B, respectively). In the first 8 hours of the fluorescence
assay as shown in Figure 2A, each ratio of αL suppressed the fluorescence increase compared to the βamyloid alone. However, after the first eight hours of the assay there was a second increase in fluorescence,
where even the 10x αL-crystallin became overwhelmed and had similar values to that of β-amyloid alone.
In contrast, the 10:1 of αB-crystallin showed complete suppression of β-amyloid formation (Figure 2B).
However, results for both αB-crystallin and αL-crystallin at 1:50 and 1:100 Aβ1-42: α-crystallin showed
similar kinetics as the chaperones became overwhelmed.
To quantify the efficiency of αL-crystallin as a molecular chaperone for β-amyloid compared to αBcrystallin, the half-times (T1/2) of fibril formation for each of the experimental conditions was determined
using the AmyloFit program (Meisl et. al. 2016). As shown in Table 1, the T1/2 values for both αL-crystallin
and αB-crystallin showed a dose-dependent response leading to T1/2 values that were all longer than the βamyloid control. The chaperone αB-crystallin showed a longer half-time than αL-crystallin for the 20x and
50x conditions, and at 10x completely suppressed fibril formation. Thus, both chaperones were effective at
reducing the kinetics of fibril nucleation/elongation. However, αL-crystallin was not as effective of a
chaperone as αB-crystallin.
SDS-PAGE was employed to determine if αL-crystallin formed an insoluble aggregate with β-amyloid
under the experimental conditions. It was expected that there would be a presence of chaperone protein in
the pellet as the concentration of αL- and αB-crystallin decreased, as this would suggest that there was an
interaction between αL-crystallin and β-amyloid, and αL-crystallin became insoluble while inhibiting fibril
elongation. Unfortunately, complex formation between αB-crystallin and αL-crystallin with β-amyloid
could not be detected by SDS-PAGE. There was no detectable presence of αB-crystallin and αL-crystallin
in the pellet following centrifugation, which indicated that there was either little to no interaction between
αB-crystallin and αL-crystallin with β-amyloid under these conditions, or it was not quantifiable by SDSPAGE. Notably, β-amyloid was also not detected in the pelleted samples, indicating that increased
centrifugal force may be needed to effectively separate these species from the soluble supernatant.

Therefore, a more sensitive form of analysis or a higher centrifugation speeds may be needed for future
studies to monitor the solubility effects between α-crystallin and β-amyloid.
NSEM was used to directly visualize the interactions between αL-crystallin and β-amyloid. Electron
micrographs from the two control conditions (Figure 4E and F) showed the difference between the two
species: β-amyloid as a helical fibril and αL-crystallin as a polydisperse oligomer (Fändrich et. al. 2011,
Kollmer et. al. 2019). The experimental conditions showed that αL-crystallin specifically interacted with
β-amyloid and decreased the fibril size as the concentration of αL-crystallin to β-amyloid increased. This
was shown by αL-crystallin aligned along the fibril and significantly smaller fibrils than that of the positive
control (Figure 4A). As the αL-crystallin concentration decreased, the prevention of amyloid elongation
decreased (Figure 4B and C). Some αL-crystallin was still present on the amyloid fibril at 50x and 100x,
but these effects were significantly diminished. Higher ordered fibril elongation occurs primarily in the
100x condition. This indicated that even in small concentrations, αL-crystallin can have a preventive effect
to the elongation of highly ordered β-amyloid fibrils. Notably, in the context of the eye lens, αL-crystallin
would be expected to be in large excess over amyloidogenic peptides and would therefore be effective at
preventing/delaying fiber formation.
The 10x αB-crystallin condition also showed interaction with β-amyloid as monitored by NSEM (Figure
4D). The chaperone was present in greater number than in the 10:1 αL-crystallin, and free αB-crystallin
was also present in solution. These micrographs in addition to the fluorescence assays validate that in the
10x αB-crystallin condition, the elongation of β-amyloid was completely suppressed. This indicated that
αB-crystallin was a more potent inhibitor of β-amyloid than αL-crystallin in vitro.
CONCLUSION
The sHsp, αB-crystallin, has been previously shown to provide cytoprotective effects in neurodegenerative
disease pathways by forming stable associations with amyloid species (Selig et. al. 2020, Mannini et. al.
2012). Due to αB-crystallin’s increased expression in Lewy bodies and senile plaques in protein aggregation
diseases, it was shown from previous literature that αB-crystallin had a strong association with a main
protein in AD, β-amyloid (Falcon et. al. 2019). Since β-amyloid has also been found to be present in age
related cataracts, it is necessary to determine whether the lens specific αL-crystallin interacted with βamyloid as a molecular chaperone in a similar manner to αB-crystallin. Using ThT fluorescence-based
chaperone assays, biochemical analysis by SDS-PAGE and structural characterization by electron
microscopy, it was observed that αL-crystallin did directly interact with β-amyloid fibrils and prevent the
elongation of β-amyloid in vitro; however, the suppression effects of αL-crystallin were not as strong as
what was found for αB-crystallin. This indicated that αL-crystallin may indeed be an effective chaperone
against β-amyloid formation, but not be as potent as αB-crystallin.
Further experimentation with αL-crystallin to examine the solubility interaction between β-amyloid and
αL-crystallin would be to use silver staining SDS-PAGE or Western Blot for a higher sensitivity for analysis
and/or increasing the centrifugal force to separate insoluble species. Moving forward, it would be beneficial
to observe the chaperone abilities of αA-crystallin with β-amyloid by similar methodologies. Since a
decrease of chaperone activity was observed for αL-crystallin compared to αB-crystallin, it would be
worthwhile to discern whether this decrease was due to the αA-crystallin present in αL-crystallin, or if there
was another factor that could not be distinguished from these experiments.
Overall, this work has expanded on the knowledge of chaperones in the eye lens and their role in protein
aggregation disease. This increased the understanding of the chaperone ability of αL-crystallin compared
to αB-crystallin in vitro and had important implications for amyloid deposition and elongation and its role
in progression in disease. Further progression of the knowledge of crystallins in the eye lens could lead to
effective drug therapeutics and less invasive methodologies for intervention of cataracts.
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sHsp – Small heat shock protein
AD – Alzheimer’s disease
PD – Parkinson’s disease
DS – Downs’ Syndrome
Aβ – β-amyloid
ThT – Thioflavin T
NSEM – Negative stain electron microscopy
APP – Amyloid-β precursor protein
CTE – C-terminal extension
ACD – α-crystallin domain
NTD – N-terminal domain
T1/2 – Half-time
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